Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-17-056

Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10)

Closed on January 19, 2018.

Posted
October 19, 2017
Close date
January 19, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
5
5 renewals
Median first-year cost
$13,006,743
$72,459,569 in all
Institutions
5
5 contact PIs
Patents
1
from 1 funded project

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. CHILDREN'S HOSP OF PHILADELPHIA1
  3. ECOG-ACRIN MEDICAL RESEARCH FOUNDATION1
  4. NRG ONCOLOGY FOUNDATION, INC.1
  5. OREGON HEALTH & SCIENCE UNIVERSITY1

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 GRB-S (O1))5
5 awards under RFA-CA-17-056 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2019COG NCTN Network Group Operations Center2U10CA180886-06Adamson, Peter C.Blaney, Susan M.CHILDREN'S HOSP OF PHILADELPHIA, PAFirst-year cost $23,995,872Study section ZCA1
FY2019Alliance for Clinical Trials in Oncology Operations Center2U10CA180821-06Bertagnolli, Monica MGeorge, SuzanneHahn, OlwenBRIGHAM AND WOMEN'S HOSPITAL, MAFirst-year cost $13,012,046Study section ZCA1
FY2019SWOG Network Group Operations Center of the NCTN2U10CA180888-06Blanke, Charles D.OREGON HEALTH & SCIENCE UNIVERSITY, ORFirst-year cost $13,006,743Study section ZCA1
FY2019NRG Oncology Network Group Operations Center2U10CA180868-06Curran, Walter J.Mannel, Robert S.Wolmark, NormanNRG ONCOLOGY FOUNDATION, INC., PAFirst-year cost $11,882,464Study section ZCA1
FY2019ECOG-ACRIN Network Group Operations Center2U10CA180820-06Odwyer, Peter JSchnall, Mitchell D.ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, PAFirst-year cost $10,562,444Study section ZCA1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

1 patent names 1 of the 5 funded projects.

  1. US 11,028,448 (opens the patent at USPTO, a PDF, in a new tab)METHODS OF IDENTIFYING RISK OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) PATHWAY INHIBITOR-INDUCED HYPERTENSIONGranted June 8, 2021 to THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL and Duke UniversityU10CA180821 · BRIGHAM AND WOMEN'S HOSPITAL, MA

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-CA-17-056: Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10) | ConductScience ScienceDex